Dabur India Limited has officially confirmed the appointment of Mr. Herjit S. Bhalla as Chief Executive Officer - India Business, effective April 23, 2026. The appointment was formalized through a regulatory filing under Regulation 30 of the SEBI Listing Regulations, updating the company's previous disclosure dated February 17, 2026.

Appointment Confirmation

The company filed an official update confirming Mr. Bhalla's joining date, which was adjusted from the initially scheduled date. The appointment details are outlined below:

Leadership Structure

Mr. Bhalla will report directly to Mr. Mohit Malhotra, who holds the position of Whole-time Director and Global Chief Executive Officer of Dabur India Limited. This reporting structure indicates the strategic importance of the India Business operations within the company's overall organizational framework.

Regulatory Compliance

The appointment was disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal communication was addressed to both BSE Limited and National Stock Exchange of India Limited, ensuring comprehensive market disclosure.

Corporate Communication

The official filing was signed by Ashok Kumar Jain, Group Company Secretary and Chief Compliance Officer, and was digitally authenticated on April 23, 2026. The announcement includes the company's BSE Scrip Code (500096) and NSE Scrip Symbol (DABUR), with information also made available on the company's official website at www.dabur.com .

This leadership appointment reflects Dabur's commitment to strengthening its management structure for its India business operations, which represents a significant portion of the company's overall operations.

Dabur India is facing regulatory scrutiny in Turkey as competition authorities have initiated an antitrust investigation into one of the company's units, according to a Bloomberg report.

Investigation Details

The Turkish competition authority has launched the antitrust probe, though specific details regarding the nature of the investigation or the particular concerns raised have not been disclosed in the available information. The investigation targets a unit of the Indian consumer goods company operating in the Turkish market.

Regulatory Impact

This development represents a significant regulatory challenge for Dabur's international operations. Antitrust investigations can potentially impact business operations, market strategies, and commercial activities in the affected jurisdiction. The outcome of such investigations can range from regulatory compliance requirements to potential penalties, depending on the findings.

Company Operations

Dabur India, known for its consumer healthcare and personal care products, has been expanding its international presence across various markets. The Turkish market represents part of the company's broader international expansion strategy, making this regulatory development particularly noteworthy for the company's global operations.